CORCEPT THERAPEUTICS INC Stock Issued During Period, Shares, Conversion of Convertible Securities
CORCEPT THERAPEUTICS INC (CORT) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 6.20 million shares for the 1-month period ending 2015-03-31, per its 10-Q filed 2016-05-04.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2016-05-04
- 2015-03-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 6.20M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|
| 2015-03-31 | 6.20M shares 10-Q · filed 2016-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |